Evolution of patients with Bronchiolitis Obliterans Syndrome (BOS) secondary to allogenic Haematopoietic Stem Cell Transplant (HSCT)

Conclusion: BOS is a high mortality complication that appears in a 15% of allogeneic HCT. Its management must be multidisciplinary because It may develops alone or associated with other organs disease. Respiratory function tests are necesary in extrapulmonary GVHD cases, as well as in patients with respiratory symptoms to detect premature pulmonary involvement and to establish early treatment.

Source: European Respiratory Journal - November 20, 2019 Category: Respiratory Medicine Authors: Martinez Vergara, A., Churruca Arrospide, M., Lopez Pereira, P., Sola Aparicio, E., Giron Moreno, R. M., Aguado Bueno, B., Aldave Orzaiz, B., Sanchez Azofra, A., Soriano Ortiz, J., Ancochea Bermudez, J. Tags: Clinical Problems Source Type: research